<DOC>
	<DOCNO>NCT03095066</DOCNO>
	<brief_summary>This multicenter , randomize , placebo-controlled study evaluate AVP-786 treatment neurobehavioral disinhibition include aggression , agitation , irritability participant traumatic brain injury ( TBI ) .</brief_summary>
	<brief_title>Study Assess Efficacy , Safety , Tolerability AVP-786 Treatment Neurobehavioral Disinhibition Including Aggression , Agitation , Irritability Patients With Traumatic Brain Injury</brief_title>
	<detailed_description>Eligible participant study must diagnosis neurobehavioral disinhibition include aggression , agitation , irritability persists brain injury . This multicenter , randomize , placebo-controlled study , consist 12 week treatment .</detailed_description>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<criteria>Participants traumatic brain injury ( TBI ) Participants neurobehavioral disinhibition symptom present trauma recovery consciousness Score â‰¥4 modify Clinical Global Impression Severity ( mCGIS ) scale Agitation/Aggression Irritability/Lability subscales Neuropsychiatric Inventory ( NPI ) scale screen baseline Participants reliable caregiver Participants diagnosis preexist developmental , mood , anxiety disorder Participants history current clinical symptom schizophrenia , schizoaffective disorder , bipolar disorder , progressive dementia , either TBI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>aggression</keyword>
	<keyword>agitation</keyword>
	<keyword>irritability</keyword>
	<keyword>non-penetrating brain injury</keyword>
	<keyword>traumatic brain injury</keyword>
	<keyword>AVP-786</keyword>
</DOC>